Ocrevus Phase 3 Trial Will Explore How Treatment Works by Viewing Changes in Spinal Fluid
…
Induction and escalation therapies in multiple sclerosis
…
Stuart Schlossman
Taking A Closer Look at Your MS Treatment Plan
…
Stuart Schlossman
OhioHealth hospital was the first to use the FDA Approved Drug, Ocrevus
…
Stuart Schlossman
Relapsing-remitting MS: Alemtuzumab boosts outcomes for black patients
…
Stuart Schlossman
Pregnant Women with Relapsing MS Can Use Copaxone Without Harming Baby, Study Indicates
…
Stuart Schlossman
No Evidence of Disease Activity Achieved in Multiple Sclerosis with Dimethyl Fumarate
…
Stuart Schlossman
Firefighter with Relapsing MS on Ocrevus: ‘I Have Really Good Days and I Have Bad Days’
…
Stuart Schlossman
Ocrevus (Ocrelizumab) Information Update
…
Stuart Schlossman
Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe
…
Stuart Schlossman
